玖紙(02689.HK)急漲12%創逾兩年高 中期多賺7.5%增派息獲大和及高盛升價至12元
玖龍紙業(02689.HK)中期多賺7.5%派息年增逾22%,大和及高盛績後分別升玖紙目標價20%及逾14%至12元。該股扭兩連跌,今早高開近4%重越10天線(9.98元),進一步升破本周一所創逾兩年高位10.54元,最高見11.12元,創27個月高,現造10.76元,急漲12%,成交增至2,820萬股,創逾兩個月高,涉資3.01億元。
玖紙公布,中期純利按年升7.5%至41.68億人民幣(下同),每股盈利89分,末期股息按年增逾22%至22分。期內,總營收按年減少6%至513.41億元;毛利率按年增加2個百分點至17.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.